(IN BRIEF) Professor Remco Tuinier and his team at Eindhoven University of Technology have developed a new method to slow the release of protein-based drugs, addressing the challenge of rapid dispersion in the body. By using polyethylene glycol (PEG) and … Read the full press release
(IN BRIEF) Look Good Feel Better, in partnership with England Netball, organized its Annual Charity Netball Tournament at the University of Warwick, raising over £32,000 for individuals undergoing cancer treatment. The event, attended by 240 netball players, featured 26 teams … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Non Profit, Science, Sports, Technology, United Kingdom
Tagged Ama Agbeze, Annual Charity Netball Tournament, Ash Dekker, Cancer, charity, England Netball, Lizzie Cooper, Look Good Feel Better, Mark Hyndman, Millie Sanders, partnership, sports, University of Warwick
(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations. This marks a significant milestone in the company’s growth strategy (#FutureFresenius) and expands treatment options for inflammatory, autoimmune diseases, and … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged #FutureFresenius, Actemra®, autoimmune diseases, Biosimilar, Cancer, cancer treatment, FDA, Food and Drug Administration, Fresenius Kabi, Genentech, Idacio®, inflammatory, inflammatory diseases, IV, IV formulation, Stimufend®, Subcutaneous formulation, subcutaneous tocilizumab biosimilar, tocilizumab, tocilizumab biosimilar, tocilizumab-aazg, Tyenne®
(IN BRIEF) Dr. Kenneth Rankin, an honorary senior lecturer at Newcastle University, was bestowed with the prestigious Researcher of the Year award at The Bone Idols 2024 ceremony for his outstanding contributions to surgical oncology. Recognized for his remarkable innovation … Read the full press release
Posted in Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology, United Kingdom
Tagged Awards, Cancer, Dr. Kenneth Rankin, leadership, national award, Newcastle University, Surgical Innovation
(IN BRIEF) Researchers in Finland have conducted a study to understand why some chronic myeloid leukaemia (CML) patients can safely discontinue their daily medication. CML is a type of blood cancer, and targeted drugs have significantly improved patient outcomes. However, … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science
Tagged Aalto University, Cancer, Chronic Myeloid Leukaemia, HUS Helsinki University Hospital, Jani Huuhtanen, Medication Discontinuation Success, partnership, patients, Satu Mustjoki, University of Helsinki
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This collaboration includes an exclusive global license (excluding China) to develop and commercialize Hengrui’s advanced PARP1 inhibitor, HRS-1167. Additionally, there is … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged ADC, antibody-drug conjugate, ATM, ATR, Cancer, CEACAM5-targeting ADC, Claudin-18.2, Danny Bar-Zohar, DDR cascade, DNA-PK, Frank Jiang, Hengrui, HRS-1167, inhibitor, Jiangsu Hengrui Pharmaceuticals Co. Ltd., M9140, Merck, metastatic colorectal cancer, oncology, PARP, PARP1, poly (ADP-ribose) polymerase 1, SHR-A1904
(IN BRIEF) Novartis has announced successful results from its Phase III NETTER-2 trial involving Lutathera, a treatment for neuroendocrine tumors (NETs). When used as a first-line treatment in combination with long-acting octreotide, Lutathera significantly improved progression-free survival in patients with … Read the full press release
(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, Cancer, David Williams, Dr Emma Fairweather, drug discovery, Emma Nolan, Enterprise Investment Funding, ISMIB, Multi-omics Platforms, Professor Anthony Hollander, Professor Patrick Eyers, pseudoenzymes, spin-out, Sulantrix, University of Liverpool
(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l’Université de Liverpool appelée Sulantrix explore de nouveaux médicaments contre le cancer ciblant des classes de pseudoenzymes jusqu’alors inexploitées. La société est dirigée par le professeur Patrick Eyers … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer, David Williams, découverte de médicaments, Dr Emma Fairweather, Emma Nolan, essaimage, financement des investissements d'entreprise, IA, ISMIB, plateformes multi-omiques, professeur Anthony Hollander, professeur Patrick Eyers, pseudoenzymes, Sulantrix, Université de Liverpool
(PRESS RELEASE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to accelerate … Read the full press release
Posted in Education, Healthcare, Investment, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biomedical sciences, brain activity, brain development, Cancer, Cardiff University, Congenital Anomalies, CRUK Beatson Institute, Degron Tagging, disease modelling, Dr Andrew Wood, Dr David Kent, Dr Michael Ashby, Dr Robert Pitceathly, Haem, Institute of Cancer Research, King’s College London, Mary Lyon Centre, microbiome, Mitochondria, mouse genetics, MRC, MRC Harwell, MRC Human Genetics Unit, MRC National Mouse Genetics Network, MURIDAE, neurodevelopmental, neuropsychiatric disease, Owen Sansom, Prof Anthony Isles, Prof Fiona Powrie, Prof Karen Blyth, Prof Karen Liu, Prof Louis Chesler, psychiatric disorders, UCL Queen Square Institute of Neurology, University of Bristol, University of Edinburgh, University of Glasgow, University of Oxford, University of York
(COMMUNIQUÉ DE PRESSE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to … Read the full press release
Author looking for a sponsor (PRESS RELEASE) JELGAVA, Latvia, 29-Mar-2022 — /EuropaWire/ — Still Alive was begun by Andrej Statskij in early 2021 in a hospital while battling a dangerous illness. It was finished later that year and received a … Read the full press release
(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abiraterone, AstraZeneca, Cancer, chemotherapy, Eastern Cooperative Oncology Group, EcoG, hormones, HRR, IDMC, Independent Data Monitoring Committee, Lynparza, mCRPC, MSD, MSD Research Laboratories, Olaparib, PARP, PROpel Phase III, prostate cancer, Roy Baynes, rPFS, Susan Galbraith
Why identical mutations cause different types of cancer Cancer development is influenced by tissue type (PRESS RELEASE) MUNICH, 20-Jul-2021 — /EuropaWire/ — Technical University of Munich (TUM), one of Europe’s leading universities, has announced that its Professor for Translational Cancer … Read the full press release
Posted in Education, Germany, Healthcare, News, Science, Technology
Tagged biliary tract cancer, Cancer, cancer drivers, cancerous diseases, Chiara Falcomatà, Dieter Saur, DKTK, extrahepatic bile duct cancer, Functional Genomics, Genes, German Cancer Consortium, Günter Schneider, human cancers, Klinikum rechts der Isar, KRAS, Molecular Oncology, oncogenes, organs, pancreatic cancer, PIK3CA, Roland Rad, Technical University of Munich, treatment of pancreatic cancer, treatments of cancerous diseases, TUM, University Medical Center Göttingen
(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science
Tagged American Cancer Association, B66, bioscience, Biotech, bladder, breast, Cancer, colorectal, Dr Eric Metzger, Freiburg, Germany, histone methyltransferase, inhibitors, KMT9, lung cancer, Manfred Jung, Mike Dunckley, pharma, Professor Manfred Jung, Professor Roland Schule, Professors Roland Schule, prostate cancer, prostate tumours, University of Freiburg
Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release
Posted in France, Healthcare, News, Non Profit, Pharma & Biotech, Society
Tagged access to medicines, Cancer, cardiovascular disease, chronic diseases, climate change, Corporate Social Responsibility, CSR strategy, Diabetes, diversity, environmental protection program, Fabry, Gaucher, healthcare professionals, Inclusion, malaria, nonprofit unit, open letter, Paul Hudson, Pharmaceutical, Planet Mobilization, polio, Pompe diseases, preservation of the environment, rare diseases, Sanofi, Sanofi Global Health, sleeping sickness, support for vulnerable communities, tuberculosis, vaccines, WHO, World Health Organization, Zero plastic packaging
(PRESS RELEASE) Sophia Antipolis Cedex, France, 29-Mar-2021 — /EuropaWire/ — European Society of Cardiology (ESC) announces that its online scientific congress EHRA 2021 will be held 23 to 25 April online. Highlights of the congress are the latest practice-changing research … Read the full press release
Posted in Artificial Intelligence (AI), Education, France, Healthcare, Internet & Online, News, Science, Technology
Tagged ablation procedure, apps, arrhythmias, artificial-intelligence, atrial fibrillation treatment, blood pressure, Cancer, cannabis, cardiac arrest, cardiac arrhythmia, cardiac devices, congenital heart diseases, defibrillator, Drones, EHRA, EHRA 2021, electrophysiology, ESC, European Heart Rhythm Association, European Society of Cardiology, GeneralAtrial Fibrillation, heart disorders, heart rate, heart rhythm, heart rhythm disorders, ICD, implantable cardioverter defibrillator, mental health, pregnancy complications, Professor Isabelle Van Gelder, scientific congress, smartwatches, sudden cardiac arrest, Weight loss
(PRESS RELEASE) LONDON, 15-Feb-2021 — /EuropaWire/ — British multinational insurance company Aviva to help its protection customers living with cancer get access to the emotional, clinical and financial support they need through a new partnership agreement with leading UK cancer … Read the full press release
Posted in Healthcare, Insurance, News, United Kingdom
Tagged Aviva, Cancer, cancer diagnosis, charity, COVID-19, critical illness claims, DigiCare+, DigiCare+ Workplace, financial claim payment, insurance, Macmillan Cancer Support, Macmillan Clinical Nurse Specialists, Natasha Parker, NHS, NHS services, pandemic, Paul Brencher, protection claims, protection customers, UK cancer charity
Plans in place to become a top 10 global contributor (PRESS RELEASE) BERKSHIRE, 11-Sep-2020 — /EuropaWire/ — British multinational telecommunications company Vodafone (LON: VOD) has announced it has become UK’s top daily contributor of computer processing power to the World … Read the full press release
Posted in Healthcare, Internet & Online, News, Science, Society, Technology, Telecom, United Kingdom
Tagged 5G, Cancer, Cloud, computing processing power, coronavirus research, COVID-19, DreamLab, human health, Internet of Things, IoT, IT, Johan Wibergh, poverty, processing power, Sami Gabriel, scientific research, supercomputers, sustainability, virtual machines, vodafone, Vodafone Foundation, World Community Grid
uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances personalised healthcare with development of image analysis algorithms using artificial intelligence Faster, more accurate … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?